Contracting ROI | eMAX Health

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Launch plans rarely survive first contact with payers. One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access. Then they tested it with MAVA®. Launch...

A New Federal Healthcare Advisory Committee: Implications for Pharma Market Access

The Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) recently announced the creation of a new Healthcare Advisory Committee—a body tasked with improving how care is financed and delivered under federal insurance...

MFN Deadline Is Here: How Pharma Teams Can Respond Strategically

𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗹𝗲𝗿𝘁: 𝗠𝗙𝗡 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝗜𝘀 𝗛𝗲𝗿𝗲. 𝗜𝘀 𝗬𝗼𝘂𝗿 𝗧𝗲𝗮𝗺 𝗥𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝗪𝗵𝗮𝘁 𝗖𝗼𝗺𝗲𝘀 𝗡𝗲𝘅𝘁? June 11 marks the end of the voluntary compliance window under the Most-Favored-Nation (MFN) Executive Order. If your organization hasn’t finalized a pricing strategy, the time for...

Rebate Strategy Decisions Just Got Easier | Contracting ROI with MAVA®

Rebate Strategy Decisions Just Got Easier. Pharma teams can’t afford to guess when it comes to contracting strategy. The stakes are too high, and the variables too complex. That’s why eMAX Health Systems built the Contracting ROI module into MAVA®. It helps...

Executive Insight: What Pharma Leaders Need to Know – By Julian Casciano, Chairman & CEO, eMAX Health Systems

As pricing pressures intensify, timelines compress, and policy changes take hold, manufacturers are rethinking how they gather and apply strategic insight. We sat down with Julian Casciano, President and CEO of eMAX Health Systems, to get his perspective on what...

« Older Entries

MAVA in Action: Launch Strategy Shifted in Just 5 Days

A New Federal Healthcare Advisory Committee: Implications for Pharma Market Access

MFN Deadline Is Here: How Pharma Teams Can Respond Strategically

Rebate Strategy Decisions Just Got Easier | Contracting ROI with MAVA®

Executive Insight: What Pharma Leaders Need to Know – By Julian Casciano, Chairman & CEO, eMAX Health Systems

Search by Category:

Recent Posts:

Search by Keyword:

MAVA in Action: Launch Strategy Shifted in Just 5 Days

A New Federal Healthcare Advisory Committee: Implications for Pharma Market Access

MFN Deadline Is Here: How Pharma Teams Can Respond Strategically

Rebate Strategy Decisions Just Got Easier | Contracting ROI with MAVA®

Executive Insight: What Pharma Leaders Need to Know – By Julian Casciano, Chairman & CEO, eMAX Health Systems

Search by Category:

Recent Posts:

Search by Keyword:

Cookie Consent

Your Privacy Choices

Strictly Necessary (Always Active)

Analytics & Performance

Marketing & Advertising